As plant-based eating continues its mainstream ascent, a largely overlooked hazard deserves closer attention: the fungal toxin load embedded in the ingredients that make up meat and dairy alternatives. Unlike animal products, grain-, legume-, and nut-based alternatives carry a distinct mycotoxin fingerprint — one that scales upward as substitution rates increase, and hits youngest consumers hardest.
This risk-profiling study analyzed mycotoxin occurrence data from 413 plant-based meat alternatives (PBMAs) and plant-based beverages (PBBs) sold in Italy and the UK, modeling dietary exposure under 25%, 50%, and 100% substitution scenarios across age groups. Nineteen mycotoxins were assessed, including aflatoxins B1/B2/G1/G2, fumonisins B1/B2, ochratoxin A (OTA), deoxynivalenol (DON), zearalenone, HT-2 and T-2 toxins, and Alternaria toxins (alternariol and alternariol monomethyl ether). Aflatoxin exposure generated margins of exposure below 10,000 — a conventional threshold signaling potential health concern — across nearly all scenarios in both countries. OTA risk escalated with higher substitution levels, particularly among infants and children, who face proportionally greater exposure due to lower body weight. The highest cumulative non-tolerable exposures emerged for Alternaria toxins and HT-2+T-2 combinations, especially when both PBMAs and PBBs were consumed together.
This study adds important nuance to the plant-based transition narrative. While reducing animal product consumption carries well-documented cardiovascular and metabolic benefits, the fungal contamination profile of cereal and legume matrices is meaningfully different from that of meat and cow's milk. Mycotoxins are not eliminated by cooking or processing, and several — including aflatoxin B1 and fumonisins — are classified as possible or probable human carcinogens by IARC. The divergence between Italian and British exposure patterns likely reflects differences in raw material sourcing and regional agricultural practices, suggesting contamination risk is not uniform across European markets. Critically, this is a probabilistic exposure model, not a clinical outcome study, so it cannot quantify actual disease burden. Nonetheless, for families transitioning children to predominantly plant-based diets, this research flags an underappreciated dimension of food safety that warrants regulatory attention and product-level mycotoxin monitoring.
